About Lodestone Biomedical
Lodestone Biomedical is a private company based in Lebanon, New Hampshire. It has reported $1,185,000 raised in four offerings on Form D since July 2017.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 29, 2025 | Jul 9, 2025 | $75,000of $2.0M target | 1 | $75,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Dec 1, 2021 | Dec 14, 2021 | $450,000of $1.0M target | 6 | $75,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Mar 17, 2020 | Apr 6, 2020 | $110,000of $400K target | 3 | $36,667 | Debt, OptionsRule 506(b) | Form D ↗ |
| Jul 6, 2017 | Jul 13, 2017 | $550,000of $600K target | 7 | $78,571 | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, four offerings | $1,185,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Lodestone Biomedical's Form D filed Jul 9, 2025.
SD
Solomon Diamond
President and director
Earlier filings also listed Lidia Valdes (ceo and director, last listed Jul 2017).